141 related articles for article (PubMed ID: 1841807)
1. [Arterial hypertension, correlated factors and cardiovascular risk].
Pessina AC; Casiglia E; Rossi GP; Semplicini A
Cardiologia; 1991 Dec; 36(12 Suppl 1):67-78. PubMed ID: 1841807
[TBL] [Abstract][Full Text] [Related]
2. [Hypertension: when to consider it a risk factor?].
Pessina AC; Rossi GP
Recenti Prog Med; 1992 Sep; 83(9):515-9. PubMed ID: 1439121
[TBL] [Abstract][Full Text] [Related]
3. [Antihypertensive treatment and left ventricular hypertrophy].
Agabiti-Rosei E; Muiesan ML; Rizzoni D
Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
5. [Cardio-protection and cardio-reparation in systemic arterial hypertension].
Vallés Belsué F; Anguita Sánchez M
Rev Esp Cardiol; 1997; 50 Suppl 4():49-52. PubMed ID: 9411587
[TBL] [Abstract][Full Text] [Related]
6. [Relation between cardiac hypertrophy and changes in the large arterial trunks. Role of the renin-angiotensin system].
Benetos A
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():21-4. PubMed ID: 7646306
[TBL] [Abstract][Full Text] [Related]
7. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
Vallotton MB; Braconi-Quintaje S; Lang U
Praxis (Bern 1994); 1997 Feb; 86(7):234-7. PubMed ID: 9139339
[TBL] [Abstract][Full Text] [Related]
9. Left-ventricular hypertrophy and coronary artery disease.
Pierdomenico SD
Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
[No Abstract] [Full Text] [Related]
10. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.
Mansoor GA; Massie BM
Blood Press Monit; 1999; 4 Suppl 1():S19-22. PubMed ID: 10822413
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
13. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
Schmieder RE; Messerli FH
Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
[TBL] [Abstract][Full Text] [Related]
14. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
16. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
17. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
Amabile G
Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension--heart rate and cardiovascular risk].
Bénétos A
Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1371-6. PubMed ID: 11190282
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular abnormalities in patients with obstructive sleep apnoea syndrome].
Myśliński W; Dybała A; Mosiewicz J; Prystupa A; Hanzlik J
Wiad Lek; 2005; 58(1-2):78-83. PubMed ID: 15991558
[TBL] [Abstract][Full Text] [Related]
20. [Ventricular hypertrophy as an expression of hypertensive damage].
Chiariello M; Betocchi S
Cardiologia; 1991 Dec; 36(12 Suppl 1):79-84. PubMed ID: 1841809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
